Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanbei Qing
- Development stage
- Phase 4
- Lead developer
- Jichuan Pharmaceutical Group
- Modality
- Small Molecules, Drug Delivery Systems
- Administration
- Oral
01
Overview
Chuanbei Qing is an oral solution containing a concentrate of magnesium sulfate, sodium sulfate, and potassium sulfate. It is developed for intestinal preparation before colonoscopy in adult patients. These salts act as osmotic laxatives, drawing water into the bowel to induce watery diarrhea, thereby cleansing the colon for a clear view during the procedure. The drug is being studied in clinical trials by Jichuan Pharmaceutical Group Co. LTD and Peking Union Hospital, Chinese Academy of Medical Sciences.
Beyond the preview
Go deeper on Chuanbei Qing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chuanbei Qing.